Preventing or suppressing lactation. Disorders caused by hyperprolactinemia: amenorrhoea, irregular menstruation, infertility, dairy secretion (for women) or impotence, decreased libido (for men).
SP Cabergolin is given orally, preferably after a meal. Prevention of lactation: Single dose (2 tablets on the first day after birth). Lactation suppression: 1/2 tablet every 12 hours for 2 days. This regimen is better tolerated than the single dose for this patient group, with fewer side effects, especially hypotensive symptoms.
Treatment of hyperprolactinemia: The drug is given once or twice a week (eg, months, or months and Wednesdays). Initial doses are usually low (1/2 tb - 1 tb per week) and will be adjusted by your doctor. Depending on the therapeutic response and tolerability. Therefore, it is important to visit the doctor regularly to check the response to treatment.
Cautions and precautions
SP Cabergolin (Dostinex)will not be given to people who have experienced unusual or allergic reactions to SP Cabergolin or any other ergot alkaloid derivative. It is contraindicated in patients with hepatic impairment and toxic load. Dostinex will not be given at the same time as antipsychotic drugs or women with post-partum psychosis.
If you suffer from cardiovascular disease, Raynaud's syndrome, kidney failure, peptic ulcer, gastrointestinal haemorrhage, psychotic illness, especially hypertension, or taking medicines that lower blood pressure, it is important to tell your doctor. Do not take medicines if you are pregnant or want to start or continue breast-feeding.
If you have taken SP Cabergolin for the inhibition / suppression of lactation and the treatment did not work, avoid breastfeeding and contact your doctor. Before taking Dostinex, any pregnancy suspicion should be removed and a local contraceptive used during treatment.
If you become pregnant during treatment, discontinue treatment immediately and consult your doctor. Long-term treatment with Dostinex requires a regular gynecological evaluation, including cervical and endometrial cytology.
There are medicines (such as antiemetics, antihypertensive, psychotropic and macrolide antibiotics, such as erythromycin) that can affect the activity and tolerability of SP Cabergolin.